Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
RNAi Technology
RNAi
DR4 siRNA (h)
Supplier Images
Published Figures
DR4 siRNA (h)
DR4 siRNA (h) from Santa Cruz Biotechnology, Inc.
Be the first to write a review!
Citations:
(15)
Figures:
(2)
Supplier Page
Supplier Page from
Santa Cruz Biotechnology, Inc. for
DR4 siRNA (h)
Description
DR4 siRNA (h)
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
DR4 siRNA (h)
Company
Santa Cruz Biotechnology, Inc.
Price
$293.00
Supplier Page
View Company Product Page
Catalog Number
sc-35218
Gene Name
tumor necrosis factor receptor superfamily, member 10a
Quantity
10 µM
Species
human
NCBI Full Gene Name
TNF receptor superfamily member 10a
NCBI Gene Aliases
APO2, CD261, DR4, TRAILR-1, TRAILR1
Type
siRNA/dsRNA
Add to Compare List
Santa Cruz Biotechnology, Inc.
10410 Finnell Street
Dallas
,
Texas
75220
United States
Phone
: 1-800-457-3801
831-457-3801
Company Profile
Website:
http://www.scbt.com/
Citations (15)
(1)
Death receptor 5 promotes tumor progression in gastric cancer
FEBS Open Bio
November 14, 2023
Junbing Chen, Lin Li, Longtao Huangfu, Hong Du, Xin Ji, Xiaofang Xing, Jiafu Ji
gray‐scale value using imagej (NIH).
RNA interference
The si‐Control (
sc‐37007
) and siRNA of
DR4
(
sc‐35218
) or
DR5
(
sc‐40237
) were purchased from
Santa Cruz
. Multiple siRNAs were pooled to interfere with the
(2)
Decitabine enhances the tumoricidal potential of TRAIL via the epigenetic regulation of death receptor 4 in gastric cancer
Journal of gastrointestinal oncology
December 1, 2022
Li L, Niu Q, Zhu Y, Fan B, Yang G.
(3)
Licochalcone B induces DNA damage, cell cycle arrest, apoptosis, and enhances TRAIL sensitivity in hepatocellular carcinoma cells
Chemico-biological interactions
September 25, 2022
Zhang YY, Feng PP, Wang HF, Zhang H, Liang T, Hao XS, Wang FZ, Fei HR.
(4)
The miR-372-ZBTB7A Oncogenic Axis Suppresses TRAIL-R2 Associated Drug Sensitivity in Oral Carcinoma
Frontiers in oncology
January 1, 2020
Yeh LY, Yang CC, Wu HL, Kao SY, Liu CJ, Chen YF, Lin SC, Chang KW.
(5)
RUNX3 enhances TRAIL-induced apoptosis by upregulating DR5 in colorectal cancer
Oncogene
May 1, 2019
Kim BR, Park SH, Jeong YA, Na YJ, Kim JL, Jo MJ, Jeong S, Yun HK, Oh SC, Lee DH.
(6)
Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma
Nature communications
March 8, 2019
Park JS, Oh Y, Park YJ, Park O, Yang H, Slania S, Hummers LK, Shah AA, An HT, Jang J,
et al
.
(7)
Involvement of DR4/JNK pathway-mediated autophagy in acquired TRAIL resistance in HepG2 cells
International journal of oncology
November 1, 2016
Lim SC, Jeon HJ, Kee KH, Lee MJ, Hong R, Han SI.
5'-ACGAAAUUGGUG GCGUAGG (dtdt)-3' (antisense) were purchased from Bioneer (Daejeon, Korea). siRNA targeting
DR4
(#2) (
sc-35218
) was purchased from
Santa Cruz Biotechnology
. Cells were individually
transfected
with siRNA oligonucleotides
(8)
Effect of vitamin E succinate on the expression of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor in gastric cancer cells and CD4(+) T cells
Molecular bioSystems
November 1, 2015
Hou L, Zhang H, Xu P, Zhang L, Zhang X, Sun Y, Huang X, Wu K.
(9)
Myriocin induces apoptotic lung cancer cell death via activation of DR4 pathway
Archives of pharmacal research
April 1, 2014
Choi KE, Jung YS, Kim DH, Song JK, Kim JY, Jung YY, Eum SY, Kim JH, Yoon NY, Yoo HS,
et al
.
(10)
Blockage of Stat3 enhances the sensitivity of NSCLC cells to PI3K/mTOR inhibition
Biochemical and biophysical research communications
February 21, 2014
Jin HO, Lee YH, Park JA, Kim JH, Hong SE, Kim HA, Kim EK, Noh WC, Kim BH, Ye SK,
et al
.
(11)
Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway
Toxicology and applied pharmacology
January 1, 2012
Jo M, Park MH, Kollipara PS, An BJ, Song HS, Han SB, Kim JH, Song MJ, Hong JT.
(12)
2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression
Molecular cancer therapeutics
October 1, 2011
Stolfi C, Caruso R, Franzè E, Rizzo A, Rotondi A, Monteleone I, Fantini MC, Pallone F, Monteleone G.
(13)
Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis
Cell cycle (Georgetown, Tex.)
August 15, 2011
Martínez-Paniagua MA, Baritaki S, Huerta-Yepez S, Ortiz-Navarrete VF, González-Bonilla C, Bonavida B, Vega MI.
(14)
Isoangustone A present in hexane/ethanol extract of Glycyrrhiza uralensis induces apoptosis in DU145 human prostate cancer cells via the activation of DR4 and intrinsic apoptosis pathway
Molecular nutrition & food research
September 1, 2010
Seon MR, Lim SS, Choi HJ, Park SY, Cho HJ, Kim JK, Kim J, Kwon DY, Park JH.
(15)
Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment
Apoptosis : an international journal on programmed cell death
June 1, 2008
Mendoza FJ, Ishdorj G, Hu X, Gibson SB.
<<
<
>
>>
Reviews
Be the First to Write a Review!
DR4 siRNA (h) from Santa Cruz Biotechnology, Inc.
Supplier Page
View Company Product Page
$293.00
Product Specs
Company Info
Citations
Reviews
Back To Top